Animal studies demonstrate a neuroprotective effect of intravenous BDNF–gene-modified human mesenchymal stem cells injection in reducing infarct size [21,22], as well as intraventricular BDNF pretreatment preserving pyramidal cell integrity in the hippocampus post-ischemia [23]. This evidence concerns the gene BDNF and ischemia.